Contractor
GENENTECH INC
SOUTH SAN FRANCISCO, CA
- UEI
- F7F8GZXL7Q93
- Resolved by
- uei
- Confidence
- 1.000
Obligated to date
$252,794,8861
Awards
2
Agencies served
1
Active from Sep 27, 2018 to Jul 29, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 75A50118D00036 ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA | Department of Health and Human Services | — | Sep 27, 2018 | — |
| 75F40125C00069 THIS PROJECT FOCUSES ON ADDRESSING CRITICAL CHALLENGES IN THE DESIGN AND ANALYSIS OF HYBRID RANDOMIZED CONTROLLED TRIALS (RCTS) IN LONGITUDINAL SETTINGS. THE FIRST GOAL IS TO DEVELOP CAUSAL METHODOLOGIES FOR MANAGING DIVERSE MISSING DATA PATTERNS IN | Department of Health and Human Services | MD | Mar 20, 2026 | $1,085,530 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier F7F8GZXL7Q93, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Sep 12, 2026.